🔎 Trials Near Me

Home › Colorectal Cancer › NCT05447923

Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities

RecruitingHealthy volunteers welcome

Colorectal Cancer Screening in Black and Underserved Communities in the Phoenix Metro Area: Addressing Disparities in Cancer Prevention

Who can join

Ages 45 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Age 45 years of age or older
* No prior history of colorectal cancer or colon polyps
* No first-degree family history of colorectal cancer who were diagnosed under age 60
* No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
* Have not undergone a colonoscopy in the last 5 years
* Have not had a fecal immunochemical test (FIT) test within the last year
* Participants that attend 4 predominantly African American churches within the Phoenix Community and extend the study opportunity as feasible to other underserved communities in the Phoenix Metro area

About the study

This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.

What is being tested

Sponsor: Mayo Clinic · Participants: 450 · Started: May 22, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT05447923

Locations in the U.S.

ArizonaMayo Clinic in Arizona, Scottsdale

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.